Ovarian masses: changing clinico histopathological trends

Journal of Obstetrics and Gynaecology of India
So SharadhaV Indra

Abstract

To study the clinical and histopathological presentation of ovarian masses. Retrospective analysis of 205 cases from May 2009 to June 2013. Incidence of ovarian masses was 6.9 %. Among 205 cases, 68 % were neoplastic. Among the neoplasms, 87.8 % were benign, 10 % malignant, and 2.2 % borderline. Mean ages of malignant and benign neoplasm were 41 and 39 years, respectively. 42.9 % malignant tumors presented with non-specific abdominal and constitutional symptoms. Serous cystadenoma was the commonest benign tumor (67 %) followed by Mucinous (19 %) and Dermoid (11.6 %). Most common malignant ovarian tumor was Serous cystadenocarcinoma (42.9 %). Out of the malignant cases, all were primary except one secondary deposit from Non-Hodgkin's Lymphoma. Only 28.6 % presented at stage I, remaining presented at stage III/IV. Ovarian neoplasms have twice the incidence of non-neoplasms. Mean age of malignant tumors is decreased. Rising trend in Mucinous cystadenoma is noted.

References

Mar 12, 2005·CA: a Cancer Journal for Clinicians·D Max ParkinPaola Pisani
Apr 4, 2006·Fertility and Sterility·Ali MahdaviFarr Nezhat
Jan 25, 2012·Journal of Cancer Research and Therapeutics·Santosh Kumar MondalSwapan Kumar Sinha
Jan 17, 2014·Journal of Obstetrics and Gynaecology of India·Dilip Kumar Dutta, Indranil Dutta
Apr 4, 2015·Gynecologic Oncology·John ButlerAndrew Nordin

❮ Previous
Next ❯

Citations

Sep 7, 2019·South Asian Journal of Cancer·Rojna RaiUgyen Tshomo

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.